Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | ||||
|---|---|---|---|---|---|
| Revenue | 26.50% | -2.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.50% | -2.85% | |||
| Cost of Revenue | 45.24% | 0.20% | |||
| Gross Profit | 14.77% | -4.65% | |||
| SG&A Expenses | -19.09% | 2.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.89% | 1.80% | |||
| Operating Income | 47.09% | -8.79% | |||
| Income Before Tax | 69.16% | -71.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 69.16% | -71.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 69.16% | -71.50% | |||
| EBIT | 47.09% | -8.79% | |||
| EBITDA | 48.75% | -8.13% | |||
| EPS Basic | 75.71% | -89.19% | |||
| Normalized Basic EPS | 47.06% | 10.53% | |||
| EPS Diluted | 75.71% | -89.19% | |||
| Normalized Diluted EPS | 47.06% | 10.53% | |||
| Average Basic Shares Outstanding | 21.31% | 7.49% | |||
| Average Diluted Shares Outstanding | 21.31% | 7.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||